Just 10 per cent of men in Britain would use a male contraceptive, survey finds
19th April 2016 13:33 - Pharmaceutical
According to a recent survey, just 10 per cent of men would use a male contraceptive, with many men concerned about the long term effects it could have.
The research comes in the wake of news that a non-hormonal male contraceptive, Vasagel, is expected to enter the British market between 2018 and 2020.
In December 2014, alternative research from the Centre for Epidemiology & Health presented entirely different findings from the more recent study, with at least 50 per cent of men saying that they would use the contraceptive – a 40 per cent decrease in two years.
Another survey questioned 2,681 men in Britain, who had been in a relationship with their partner for at least six months, about male contraceptive.
Conducted by VouchersCodePro.co.uk, the research revealed that approximately two in three respondents agreed that they use contraceptives; however, 25 per cent said that they do not use a method of contraception at all.
Of the men in relationships, 89 per cent said that they would not take a male contraceptive; however, 21 per cent said that they would be scared of the potential long-term effects it could have. A further 24 per cent believe that it is the female’s responsibility to take contraception.
Speaking to the Sun newspaper, a spokesman for VoucherCodesPro said of the results:
“I am really shocked by these results and I’m sure a few females will no doubt feel angry towards the male view that contraception should be a woman’s responsibility.”
The Executive Director for the Male Contraception Initiative, Aaron Hamlin, said of the issue:
“As many women would at least attest, avoiding hormone would be a luxury – ensuring that contraception was worry and side-effect free. Male contraception is bound to make a lot of guys happy.”
Sign up for free insights from your sector…
We hope that you have found this article useful. This section is freely available for all to use. Please help support it by liking us or following us on our social media platforms:
For updated Pharmaceutical insights please follow us on @DJS_Pharma or use our RSS feed